These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23633479)

  • 1. Editorial: Leukocytes in tularemia--so many cells, so little time.
    Allen LA
    J Leukoc Biol; 2013 May; 93(5):641-4. PubMed ID: 23633479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.
    Melillo AA; Foreman O; Elkins KL
    J Leukoc Biol; 2013 May; 93(5):657-67. PubMed ID: 23440500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Proinflammatory cytokines in pneumonic tularemia: too much too late?
    Cowley SC
    J Leukoc Biol; 2009 Sep; 86(3):469-70. PubMed ID: 19720615
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phagocytic activity of the neutrophils in tularemia in animals with varying infective sensitivity].
    Dunaeva TN; Shlygina KN
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):22-6. PubMed ID: 1108522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytochemical changes in the peripheral blood leukocytes of guinea pigs inoculated against plague, tularemia and anthrax].
    Safronova VM; Loktev NA; Basilova GI; Pilipenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jul; (7):73-6. PubMed ID: 6812331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
    Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
    Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.
    Crane DD; Scott DP; Bosio CM
    PLoS One; 2012; 7(3):e33349. PubMed ID: 22428026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathological studies on experimental immunity of tularemia with special reference to histological difference between immunity and interference phenomenon in tularemia].
    KIKUTA K
    Nihon Byori Gakkai Kaishi; 1961; 50():515-43. PubMed ID: 14455898
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
    Surcel HM; Syrjälä H; Karttunen R; Tapaninaho S; Herva E
    Infect Immun; 1991 Jun; 59(6):1948-53. PubMed ID: 1674737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of serotonin on immune competent cells of biomodels under the conditions of vaccination against plague and tularemia].
    Kliueva SN; Kravtsov AL; Shchukovskaia TN
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):32-8. PubMed ID: 25842950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibility of simultaneous vaccination against tularemia and brucellosis. I. Indices of immunologic transformation in guinea pigs following simultaneous subcutaneous and combined vaccination against tularemia and brucellosis].
    PILIPENKO VG; POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Apr; 4():52-7. PubMed ID: 14387221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibility of simultaneous vaccination against tularemia and brucellosis. III. Indices of immunobiological changes in guinea pigs vaccinated simultaneously with tularemia and brucellosis vaccines by intradermal route].
    PILIPENKO VG; POLIAKOVA AM; SHCHEKINA TA
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Mar; 27(3):79-83. PubMed ID: 13325946
    [No Abstract]   [Full Text] [Related]  

  • 13. [The determination of the duration of postvaccinal immunity against tularemia].
    Savel'eva RA; Ananova EV; Pronin AV; Fominykh EA; Rodionova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):51-2. PubMed ID: 8553755
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of pre-existing immunity against tularemia and brucellosis on the efficacy of vaccination with plague EB vaccine administered primarily in a combined plague, tularemia and brucellosis vaccine].
    Pilipenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Feb; 45(2):101-5. PubMed ID: 5650712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of antibodies against tularemia following immunization with a live tularemia vaccine].
    Richter J; Vítková V; Stehlík J; Minaríková H
    Cesk Epidemiol Mikrobiol Imunol; 1965 Jul; 14(4):221-4. PubMed ID: 4220875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of a complex living vaccine against plague, tularemia, brucellosis and anthrax. I. Compatibility of living vaccines (plague, tularemia, brucellosis and anthrax) in experimental conditions in guinea pigs].
    VERENINOVA NK; SMIRNOVA EI; KALACHEVA NF; KUZNETSOVA NI; KARASEVA ZN
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Nov; 29(11):45-52. PubMed ID: 13626100
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the study of revaccination in experimental and human tularemia].
    MATVEETS LS
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Feb; 31():14-22. PubMed ID: 13853861
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the pathogenesis of tularemia. III. Survival of B. tularense in normal and immunized rabbits.
    SKRODZKI E
    Arch Immunol Ther Exp (Warsz); 1961; 9():509-17. PubMed ID: 13913722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Certain aspects of immunity of tularemia].
    OLSUF'EV NG; DUNAEVA TN; TSVETKOVA EM
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Jun; 28(6):13-5. PubMed ID: 13497173
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the pathogenesis and immunity of tularemia. I. The demonstration of a protective antibody in mouse serum.
    PANNELL L; DOWNS CM
    J Infect Dis; 1953; 92(2):195-204. PubMed ID: 13052966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.